AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 51 filers reported holding AGILE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $12,000 | -96.1% | 24,153 | -89.4% | 0.00% | – |
| Q2 2021 | $305,000 | +317.8% | 228,806 | +558.4% | 0.00% | – |
| Q1 2021 | $73,000 | +46.0% | 34,751 | +99.8% | 0.00% | – |
| Q4 2020 | $50,000 | -19.4% | 17,394 | -14.9% | 0.00% | – |
| Q3 2020 | $62,000 | -47.5% | 20,433 | -67.8% | 0.00% | – |
| Q1 2020 | $118,000 | +247.1% | 63,379 | +381.4% | 0.00% | – |
| Q1 2018 | $34,000 | -77.2% | 13,166 | -76.1% | 0.00% | – |
| Q4 2017 | $149,000 | -51.8% | 55,105 | -33.0% | 0.00% | – |
| Q2 2017 | $309,000 | -23.7% | 82,272 | +74.4% | 0.00% | – |
| Q2 2015 | $405,000 | -32.2% | 47,180 | -26.7% | 0.00% | – |
| Q1 2015 | $597,000 | +71.6% | 64,352 | +13.6% | 0.00% | – |
| Q4 2014 | $348,000 | -43.1% | 56,641 | -32.4% | 0.00% | – |
| Q3 2014 | $612,000 | +215.5% | 83,824 | +277.0% | 0.00% | – |
| Q2 2014 | $194,000 | – | 22,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 4,668,763 | $43,278,000 | 14.12% |
| Aisling Capital LLC | 2,983,797 | $27,660,000 | 3.62% |
| INVESTOR AB | 3,510,189 | $32,539,000 | 2.91% |
| Foresite Capital Management II, LLC | 459,266 | $4,257,000 | 2.52% |
| RA Capital Management | 1,458,792 | $13,523,000 | 1.34% |
| Sio Capital Management, LLC | 203,732 | $1,889,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 80,959 | $750,000 | 0.63% |
| Pinnacle Wealth Management Advisory Group, LLC | 49,623 | $460,000 | 0.41% |
| CAXTON CORP | 26,736 | $248,000 | 0.30% |
| Cormorant Asset Management, LP | 182,053 | $1,688,000 | 0.26% |